期刊文献+

沙库巴曲缬沙坦治疗顽固性心力衰竭的疗效与安全性观察 被引量:10

The efficacy and safety of entresto in treatment of patients with refractory heart failure
下载PDF
导出
摘要 目的探讨沙库巴曲缬沙坦治疗顽固性心力衰竭中的疗效及安全性。方法选择心内科住院的顽固性心力衰竭患者80例,分为观察组48例及对照组32例,两组于常规治疗基础上,观察组给予沙库巴曲缬沙坦50mg口服2次/d治疗,对照组给予米力农注射液微泵注射维持72h,所有患者出院后随访3个月,记录治疗前后血压、脑钠钛(BNP)、血肌酐、电解质、心脏超声数据,评估沙库巴曲缬沙坦的疗效及安全性。结果沙库巴曲缬沙坦可显著改善顽固性心力衰竭患者生活质量(总有效率97.9%),改善顽固心力衰竭患者左心室舒张末期内径水平[(5.78±0.54)cm vs.(5.46±0.52)cm,P<0.01]、提高左心室射血分数[(30.85±5.06)%vs.(40.21±6.16)%,P<0.01]及短轴缩短率水平[(23.00±5.15)%vs.(31.47±4.94)%,P<0.05],对电解质、血肌酐水平均无明显影响。结论沙库巴曲缬沙坦治疗顽固性心力衰竭有良好的治疗效果及较高的安全性。 Objective To evaluate the efficacy and safety of Entresto in treatment of patients with refractory heart failure. Methods 80 inpatients with refractory heart failure were divided into observation group and control group. The observation group was treated with Entresto 50 mg twice daily and the control group was treated with milrinone injection for 72 h based on conventional therapy. All cases were followed up for 3 months after discharge. Blood pressure, BNP, serum creatinine, electrolytes and echocardiographic data were recorded before and after treatment to evaluate the efficacy and safety of Entresto. Results Entresto significantly improved life quality of patients with refractory heart failure(the total effective rate is 97.9%), left ventricular end-diastolic diameter(5.78 ±0.54)cm vs.(5.46 ±0.52)cm, P <0.05, left ventricular ejection fraction(30.85 ±5.06)% vs.(40.21 ±6.16)%, P <0.05) and fraction shortening rate((23.00 ±5.15)% vs.(31.47 ±4.94)%, P <0.05)in patients with refractory heart failure. There was no adverse effect on serum electrolyte and creatinine.Conclusion Entresto is efficacy and safety in the treatment of refractory heart failure patients.
作者 柴东剑 程科云 屠晓鸣 金奇志 高珍艳 CHAI Dongjian;CHENG Keyun;TU Xiaoming(Department of Cardiology, Quzhou People’s Hospital, Quzhou 324000, China)
出处 《心电与循环》 2019年第4期301-303,308,共4页 Journal of Electrocardiology and Circulation
关键词 沙库巴曲缬沙坦 米力农注射液 顽固性心力衰竭 Entresto Milrinone injection Refractory heart failure
  • 相关文献

参考文献4

二级参考文献16

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2刘丽娟,王强,高修仁.磷酸二酯酶Ⅲ抑制药的临床应用及进展[J].新医学,2006,37(10):677-679. 被引量:48
  • 3Witteles R M,Kao D,Christopherson D. Impact of nesiritide onrenal function in patients with acute decompensated heart failureand pre-existing renal dysfunction a randomized,double-blind,placebo-controlled clinical trial[J].Journal of the American College of Cardiology,2007,(19):1835-1840.doi:10.1016/j.jacc.2007.03.071.
  • 4Mills R M,LeJemtel T H,Horton D P. Sustained hemodynamic effects of an infusion of Nesiritide(human b-type natriuretic peptide) in heart failure:a randomized,double-blind,placebocontrolled clinical trial.Natrecor Study Group[J].Journal of the American College of Cardiology,1999,(01):155-162.doi:10.1016/S0735-1097(99)00184-9.
  • 5Kawakami R,Saito Y,Kishimoto I. Over exp ression of brainnatriuretic pep tide facilitates neutrophil infiltration and cardiac ma2trixmetallop roteinase29 exp ression after acute myocardial infarction[J].Circulation,2004,(21):3306-3312.
  • 6Abraham W T,Lowes B D,Ferguson D A. Systemic hemodynamic,neurohormonal,and renal excretory ef ects of a steady-state infusion of human brain natriuretic pep tide in patients with decompensated chronic heart failure[J].Journal of Cardiac Failure,1998.37-44.
  • 7Mills R M,LeJemtel T H,Horton D P. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic pep tide) in heart failure:a randomized, double-blind, p lacebo-controlled clinical trial. Natrecor Study Group[J].Journal of the American College of Cardiology,1999.155-162.
  • 8ColucciW S,Elkayam E,Horton D P. Intravenous nesiritide,anatriuretic pep tide,in the treatment of decompensated heart failure[J].New England Journal of Medicine,2000.246-253.
  • 9Kawakami R,Saito Y,Kishimoto I. Overexp ression of brain natriuretic pep tide facilitates neutrophil infiltration and cardiac matrix metallop roteinase-9 expression after acute myocardial infarction[J].Circulation,2004.3306-3312.
  • 10无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3691

共引文献4689

同被引文献73

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部